Comparisons of weight changes between sodium‐glucose cotransporter 2 inhibitors treatment and glucagon‐like peptide‐1 analogs treatment in type 2 diabetes patients: A meta‐analysis

AIMS/INTRODUCTION: To evaluate the efficacy of weight changes from baseline of the sodium‐glucose cotransporter 2 (SGLT2) inhibitors treatment and glucagon‐like peptide‐1 (GLP‐1) analogs treatment after comparisons with a placebo in type 2 diabetes patients, and the associated factors. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xiaoling, Ji, Liwei, Chen, Yifei, Yang, Wenjia, Zhou, Lingli, Han, Xueyao, Zhang, Simin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497054/
https://www.ncbi.nlm.nih.gov/pubmed/28106956
http://dx.doi.org/10.1111/jdi.12625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497054/
https://www.ncbi.nlm.nih.gov/pubmed/28106956
http://dx.doi.org/10.1111/jdi.12625

Ejemplares similares